Watch the Dallas Symposium LIVE, and fundraiser auction
Ticket proceeds support mindat.org! - click here...
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2013, November) Reactions Weekly Vol. 1479 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions Weekly
Year2013 (November)Volume1479
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13307819Long-form Identifiermindat:1:5:13307819:2
GUID0
Full Reference(2013, November) Reactions Weekly Vol. 1479 (1) Springer Science and Business Media LLC
Plain Text(2013, November) Reactions Weekly Vol. 1479 (1) Springer Science and Business Media LLC
In(2013) Reactions Weekly Vol. 1479. Springer Science and Business Media LLC

Contains

(2013) Peri-conceptional opioid use increases neural tube defect risk. Reactions Weekly, 1479 (1) 1 doi:10.1007/s40278-013-7258-5
(2013) Safety of single vs multiple courses of antenatal steroids. Reactions Weekly, 1479 (1) 2 doi:10.1007/s40278-013-7259-4
(2013) Atrial fibrillation risk increased with bisphosphonate use. Reactions Weekly, 1479 (1) 2 doi:10.1007/s40278-013-7260-y
(2013) Postmenopausal estrogen therapy raises risk of gallstone disease. Reactions Weekly, 1479 (1) 2 doi:10.1007/s40278-013-7261-x
(2013) Survey reviews use of drug safety info in Japan. Reactions Weekly, 1479 (1) 3 doi:10.1007/s40278-013-7262-9
(2013) Prenatal paracetamol exposure may hinder neurodevelopment. Reactions Weekly, 1479 (1) 3 doi:10.1007/s40278-013-7263-8
(2013) Andexanet-α shows promise as sustained antidote to apixaban. Reactions Weekly, 1479 (1) 3 doi:10.1007/s40278-013-7264-7
(2013) FDA proposes re-scheduling of hydrocodone combination drugs. Reactions Weekly, 1479 (1) 4 doi:10.1007/s40278-013-7265-6
(2013) Latest SmPC updates based on PRAC recommendations. Reactions Weekly, 1479 (1) 4 doi:10.1007/s40278-013-7266-5
(2013) Analysis indicates melaena may be a rare ADR of roflumilast. Reactions Weekly, 1479 (1) 4 doi:10.1007/s40278-013-7267-4
(2013) Tapentadol and delusion. Reactions Weekly, 1479 (1) 4 doi:10.1007/s40278-013-7268-3
(2013) Adrenal cortical extract/pyridoxine. Reactions Weekly, 1479 (1) 5 doi:10.1007/s40278-013-7269-2
(2013) Acacia catechu/Scutellaria extract. Reactions Weekly, 1479 (1) 5 doi:10.1007/s40278-013-7270-9
(2013) Allopurinol. Reactions Weekly, 1479 (1) 5 doi:10.1007/s40278-013-7271-8
(2013) Aconitum. Reactions Weekly, 1479 (1) 5 doi:10.1007/s40278-013-7272-7
(2013) Amphotericin B lipid complex. Reactions Weekly, 1479 (1) 6 doi:10.1007/s40278-013-7273-6
(2013) Ampicillin. Reactions Weekly, 1479 (1) 6 doi:10.1007/s40278-013-7274-5
(2013) Antineoplastics. Reactions Weekly, 1479 (1) 6 doi:10.1007/s40278-013-7275-4
(2013) Amiodarone. Reactions Weekly, 1479 (1) 6 doi:10.1007/s40278-013-7276-3
(2013) Asparaginase. Reactions Weekly, 1479 (1) 7 doi:10.1007/s40278-013-7277-2
(2013) Antiretrovirals. Reactions Weekly, 1479 (1) 7 doi:10.1007/s40278-013-7278-1
(2013) Asparaginase. Reactions Weekly, 1479 (1) 7 doi:10.1007/s40278-013-7279-0
(2013) Asparaginase. Reactions Weekly, 1479 (1) 7 doi:10.1007/s40278-013-7280-7
(2013) Aspirin. Reactions Weekly, 1479 (1) 8 doi:10.1007/s40278-013-7281-6
(2013) BCG. Reactions Weekly, 1479 (1) 8 doi:10.1007/s40278-013-7282-5
(2013) Atenolol/omeprazole. Reactions Weekly, 1479 (1) 8 doi:10.1007/s40278-013-7283-4
(2013) Bendamustine/fludarabine. Reactions Weekly, 1479 (1) 8 doi:10.1007/s40278-013-7284-3
(2013) Bevacizumab/gimeracil/oteracil/tegafur. Reactions Weekly, 1479 (1) 9 doi:10.1007/s40278-013-7285-2
(2013) Bisphosphonates/various other drugs. Reactions Weekly, 1479 (1) 9 doi:10.1007/s40278-013-7286-1
(2013) Benzocaine. Reactions Weekly, 1479 (1) 9 doi:10.1007/s40278-013-7287-0
(2013) Bromocriptine/cabergoline/quinagolide. Reactions Weekly, 1479 (1) 10 doi:10.1007/s40278-013-7288-z
(2013) Bleomycin. Reactions Weekly, 1479 (1) 10 doi:10.1007/s40278-013-7289-y
(2013) Carboplatin/cisplatin/etoposide. Reactions Weekly, 1479 (1) 10 doi:10.1007/s40278-013-7290-5
(2013) Caffeine. Reactions Weekly, 1479 (1) 10 doi:10.1007/s40278-013-7291-4
(2013) Cyclophosphamide/doxorubicin/paclitaxel. Reactions Weekly, 1479 (1) 11 doi:10.1007/s40278-013-7292-3
(2013) Cyclooxygenase modulators/proton pump inhibitors/venlafaxine. Reactions Weekly, 1479 (1) 11 doi:10.1007/s40278-013-7293-2
(2013) Dabigatran etexilate. Reactions Weekly, 1479 (1) 11 doi:10.1007/s40278-013-7294-1
(2013) Charcoal/sodium polystyrene sulfonate. Reactions Weekly, 1479 (1) 11 doi:10.1007/s40278-013-7295-0
(2013) Dabigatran etexilate overdose. Reactions Weekly, 1479 (1) 12 doi:10.1007/s40278-013-7296-z
(2013) Dabigatran etexilate/various other drugs. Reactions Weekly, 1479 (1) 12 doi:10.1007/s40278-013-7297-y
(2013) Dabigatran etexilate overdose. Reactions Weekly, 1479 (1) 12 doi:10.1007/s40278-013-7298-x
(2013) Doxazosin/propranolol overdose. Reactions Weekly, 1479 (1) 13 doi:10.1007/s40278-013-7299-9
(2013) Desflurane/remifentanil. Reactions Weekly, 1479 (1) 13 doi:10.1007/s40278-013-7300-7
(2013) Dexamethasone. Reactions Weekly, 1479 (1) 13 doi:10.1007/s40278-013-7301-6
(2013) Doxycycline. Reactions Weekly, 1479 (1) 13 doi:10.1007/s40278-013-7302-5
(2013) Epinephrine. Reactions Weekly, 1479 (1) 14 doi:10.1007/s40278-013-7303-4
(2013) Eltrombopag. Reactions Weekly, 1479 (1) 14 doi:10.1007/s40278-013-7304-3
(2013) Duloxetine. Reactions Weekly, 1479 (1) 14 doi:10.1007/s40278-013-7305-2
(2013) Doxycycline. Reactions Weekly, 1479 (1) 14 doi:10.1007/s40278-013-7306-1
(2013) Estradiol/testosterone. Reactions Weekly, 1479 (1) 15 doi:10.1007/s40278-013-7307-0
(2013) Ethambutol. Reactions Weekly, 1479 (1) 15 doi:10.1007/s40278-013-7308-z
(2013) Escitalopram. Reactions Weekly, 1479 (1) 15 doi:10.1007/s40278-013-7309-y
(2013) Everolimus. Reactions Weekly, 1479 (1) 16 doi:10.1007/s40278-013-7310-5
(2013) Ethambutol. Reactions Weekly, 1479 (1) 16 doi:10.1007/s40278-013-7311-4
(2013) Ethambutol. Reactions Weekly, 1479 (1) 16 doi:10.1007/s40278-013-7312-3
(2013) Ethinylestradiol/cyproterone. Reactions Weekly, 1479 (1) 16 doi:10.1007/s40278-013-7313-2
(2013) Fluorouracil. Reactions Weekly, 1479 (1) 17 doi:10.1007/s40278-013-7314-1
(2013) Filgrastim. Reactions Weekly, 1479 (1) 17 doi:10.1007/s40278-013-7315-0
(2013) Factor IX/rifampicin. Reactions Weekly, 1479 (1) 17 doi:10.1007/s40278-013-7316-z
(2013) Factor IX/prothrombin complex concentrate. Reactions Weekly, 1479 (1) 17 doi:10.1007/s40278-013-7317-y
(2013) Factor VIII/octocog-α. Reactions Weekly, 1479 (1) 17 doi:10.1007/s40278-013-7318-x
(2013) Factor IX. Reactions Weekly, 1479 (1) 17 doi:10.1007/s40278-013-7319-9
(2013) Gemcitabine. Reactions Weekly, 1479 (1) 18 doi:10.1007/s40278-013-7320-3
(2013) Fluticasone propionate/posaconazole interaction. Reactions Weekly, 1479 (1) 18 doi:10.1007/s40278-013-7321-2
(2013) Gabapentin/various drugs. Reactions Weekly, 1479 (1) 18 doi:10.1007/s40278-013-7322-1
(2013) Heparin. Reactions Weekly, 1479 (1) 19 doi:10.1007/s40278-013-7327-9
(2013) Imipenem/cilastatin. Reactions Weekly, 1479 (1) 19 doi:10.1007/s40278-013-7323-0
(2013) Hydroxychloroquine. Reactions Weekly, 1479 (1) 19 doi:10.1007/s40278-013-7324-z
(2013) Hydroxychloroquine. Reactions Weekly, 1479 (1) 19 doi:10.1007/s40278-013-7325-y
(2013) Heparin. Reactions Weekly, 1479 (1) 19 doi:10.1007/s40278-013-7326-x
(2013) Infliximab. Reactions Weekly, 1479 (1) 20 doi:10.1007/s40278-013-7328-8
(2013) Influenza A virus vaccine-H1N1. Reactions Weekly, 1479 (1) 20 doi:10.1007/s40278-013-7329-7
(2013) Infliximab. Reactions Weekly, 1479 (1) 20 doi:10.1007/s40278-013-7330-1
(2013) Interferon-α-2b. Reactions Weekly, 1479 (1) 20 doi:10.1007/s40278-013-7331-0
(2013) Iodine-131. Reactions Weekly, 1479 (1) 21 doi:10.1007/s40278-013-7332-z
(2013) Levamisole. Reactions Weekly, 1479 (1) 21 doi:10.1007/s40278-013-7333-y
(2013) Isotretinoin. Reactions Weekly, 1479 (1) 21 doi:10.1007/s40278-013-7334-x
(2013) Ketamine. Reactions Weekly, 1479 (1) 21 doi:10.1007/s40278-013-7335-9
(2013) Interferon-β. Reactions Weekly, 1479 (1) 21 doi:10.1007/s40278-013-7336-8
(2013) Levofloxacin. Reactions Weekly, 1479 (1) 22 doi:10.1007/s40278-013-7337-7
(2013) Lithium/venlafaxine overdose. Reactions Weekly, 1479 (1) 22 doi:10.1007/s40278-013-7338-6
(2013) Levodopa/carbidopa. Reactions Weekly, 1479 (1) 22 doi:10.1007/s40278-013-7339-5
(2013) Levamisole. Reactions Weekly, 1479 (1) 22 doi:10.1007/s40278-013-7340-z
(2013) Mesalazine. Reactions Weekly, 1479 (1) 23 doi:10.1007/s40278-013-7341-y
(2013) Maraviroc. Reactions Weekly, 1479 (1) 23 doi:10.1007/s40278-013-7342-x
(2013) Lorazepam/oxazepam/trazodone. Reactions Weekly, 1479 (1) 23 doi:10.1007/s40278-013-7343-9
(2013) Mycophenolate mofetil. Reactions Weekly, 1479 (1) 24 doi:10.1007/s40278-013-7344-8
(2013) Methylnaltrexone bromide/morphine interaction. Reactions Weekly, 1479 (1) 24 doi:10.1007/s40278-013-7345-7
(2013) Methotrexate. Reactions Weekly, 1479 (1) 24 doi:10.1007/s40278-013-7346-6
(2013) Multiple drugs. Reactions Weekly, 1479 (1) 24 doi:10.1007/s40278-013-7347-5
(2013) Naproxen/piroxicam. Reactions Weekly, 1479 (1) 24 doi:10.1007/s40278-013-7348-4
(2013) Oxcarbazepine. Reactions Weekly, 1479 (1) 25 doi:10.1007/s40278-013-7349-3
(2013) Oxaliplatin. Reactions Weekly, 1479 (1) 25 doi:10.1007/s40278-013-7350-x
(2013) Olmesartan medoxomil. Reactions Weekly, 1479 (1) 25 doi:10.1007/s40278-013-7351-9
(2013) Nonacog-α. Reactions Weekly, 1479 (1) 25 doi:10.1007/s40278-013-7352-8
(2013) Paracetamol overdose. Reactions Weekly, 1479 (1) 26 doi:10.1007/s40278-013-7353-7
(2013) Paracetamol. Reactions Weekly, 1479 (1) 26 doi:10.1007/s40278-013-7354-6
(2013) Oxycodone/pregabalin interaction. Reactions Weekly, 1479 (1) 26 doi:10.1007/s40278-013-7355-5
(2013) Pamidronic acid/various other drugs. Reactions Weekly, 1479 (1) 26 doi:10.1007/s40278-013-7356-4
(2013) Paroxetine. Reactions Weekly, 1479 (1) 27 doi:10.1007/s40278-013-7357-3
(2013) Plasma. Reactions Weekly, 1479 (1) 27 doi:10.1007/s40278-013-7358-2
(2013) Pentoxifylline. Reactions Weekly, 1479 (1) 27 doi:10.1007/s40278-013-7359-1
(2013) Quetiapine. Reactions Weekly, 1479 (1) 28 doi:10.1007/s40278-013-7360-8
(2013) Roflumilast and various other drugs. Reactions Weekly, 1479 (1) 28 doi:10.1007/s40278-013-7361-7
(2013) Sodium bicarbonate. Reactions Weekly, 1479 (1) 28 doi:10.1007/s40278-013-7362-6
(2013) Prucalopride. Reactions Weekly, 1479 (1) 28 doi:10.1007/s40278-013-7363-5
(2013) Sodium bicarbonate/sodium chloride/dexamethasone. Reactions Weekly, 1479 (1) 29 doi:10.1007/s40278-013-7364-4
(2013) Tacrolimus. Reactions Weekly, 1479 (1) 29 doi:10.1007/s40278-013-7365-3
(2013) Tapentadol and various other drugs. Reactions Weekly, 1479 (1) 29 doi:10.1007/s40278-013-7366-2
(2013) Sunitinib. Reactions Weekly, 1479 (1) 29 doi:10.1007/s40278-013-7367-1
(2013) Tretinoin. Reactions Weekly, 1479 (1) 30 doi:10.1007/s40278-013-7368-0
(2013) Tocilizumab. Reactions Weekly, 1479 (1) 30 doi:10.1007/s40278-013-7369-z
(2013) Trastuzumab. Reactions Weekly, 1479 (1) 30 doi:10.1007/s40278-013-7370-6
(2013) Thiamine. Reactions Weekly, 1479 (1) 30 doi:10.1007/s40278-013-7371-5
(2013) Vancomycin. Reactions Weekly, 1479 (1) 31 doi:10.1007/s40278-013-7372-4
(2013) Vaccines. Reactions Weekly, 1479 (1) 31 doi:10.1007/s40278-013-7373-3
(2013) Valproic acid. Reactions Weekly, 1479 (1) 31 doi:10.1007/s40278-013-7374-2
(2013) Valproic acid. Reactions Weekly, 1479 (1) 31 doi:10.1007/s40278-013-7375-1
(2013) Various drugs. Reactions Weekly, 1479 (1) 32 doi:10.1007/s40278-013-7376-0
(2013) Vemurafenib. Reactions Weekly, 1479 (1) 32 doi:10.1007/s40278-013-7377-z
(2013) Vancomycin/rifampicin. Reactions Weekly, 1479 (1) 32 doi:10.1007/s40278-013-7378-y
(2013) Zoledronic acid. Reactions Weekly, 1479 (1) 33 doi:10.1007/s40278-013-7379-x
(2013) Vincristine. Reactions Weekly, 1479 (1) 33 doi:10.1007/s40278-013-7380-4
(2013) Zoledronic acid. Reactions Weekly, 1479 (1) 33 doi:10.1007/s40278-013-7381-3

See Also

These are possibly similar items as determined by title/reference text matching only.

(2013, November) Reactions Weekly Vol. 1476 (1) Springer Science and Business Media LLC
(2013, November) Reactions Weekly Vol. 1477 (1) Springer Science and Business Media LLC
(2013, November) Reactions Weekly Vol. 1478 (1) Springer Science and Business Media LLC
(2013, November) Reactions Weekly Vol. 1480 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1777 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1778 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1779 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1780 (1) Springer Science and Business Media LLC
(2019, November) Reactions Weekly Vol. 1781 (1) Springer Science and Business Media LLC
(2021, November) Reactions Weekly Vol. 1882 (1) Springer Science and Business Media LLC
(2021, November) Reactions Weekly Vol. 1881 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: August 14, 2025 18:36:52
Go to top of page